Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Proteomics Market Research Report Information By Equipment (Chromatography, Mass Spectroscopy, and Protein Microarray), By Services (Laboratory Services, Data Analysis & Services, and Others), By Application (Drug Discovery and Clinical Diagnosis), And By Region (North America, Europe, Asia-Pacific, And the Rest Of The World) โ€“ Market Forecast Till 2032


ID: MRFR/LS/5465-HCR | 90 Pages | Author: Rahul Gotadki| April 2024

Proteomics Market Segmentation


Proteomics Equipment Outlook (USD Billion, 2019-2030)




  • Chromatography




  • Mass Spectroscopy




  • Protein Microarray




Proteomics Services Outlook (USD Billion, 2019-2030)




  • Laboratory Services




  • Data Analysis & Services




  • Others




Proteomics Application Outlook (USD Billion, 2019-2030)




  • Drug Discovery




  • Clinical Diagnosis




Proteomics Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • North America Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • North America Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • US Outlook (USD Billion, 2019-2030)




    • US Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • US Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • US Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • CANADA Outlook (USD Billion, 2019-2030)




    • CANADA Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • CANADA Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • CANADA Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Europe Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Europe Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Germany Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Germany Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • France Outlook (USD Billion, 2019-2030)




    • France Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • France Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • France Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • UK Outlook (USD Billion, 2019-2030)




    • UK Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • UK Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • UK Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • ITALY Outlook (USD Billion, 2019-2030)




    • ITALY Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • ITALY Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • ITALY Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • SPAIN Outlook (USD Billion, 2019-2030)




    • Spain Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Spain Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Spain Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Rest Of Europe Outlook (USD Billion, 2019-2030)




    • Rest Of Europe Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • REST OF EUROPE Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • REST OF EUROPE Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Asia-Pacific Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Asia-Pacific Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • China Outlook (USD Billion, 2019-2030)




    • China Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • China Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • China Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Japan Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Japan Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • India Outlook (USD Billion, 2019-2030)




    • India Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • India Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • India Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Australia Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Australia Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Rest of Asia-Pacific Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Rest of Asia-Pacific Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Rest of the World Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Rest of the World Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Middle East Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Middle East Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Africa Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Africa Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Proteomics by Equipment




      • Chromatography




      • Mass Spectroscopy




      • Protein Microarray






    • Latin America Proteomics by Services




      • Laboratory Services




      • Data Analysis & Services




      • Others






    • Latin America Proteomics by Application




      • Drug Discovery




      • Clinical Diagnosis







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Equipment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porterโ€™s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Proteomics Market, by Equipment

6.1 Introduction

6.2 Chromatography

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3 Mass Spectroscopy

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.4 Protein Microarray

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.5 X-ray Crystallography

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.6 Protein Fractionation

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.7 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 7. Global Proteomics Market, by Service

7.1 Introduction

7.2 Laboratory Service

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3 Data Analysis and Services

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 8. Global Proteomics Market, by Application

8.1 Introduction

8.2 Drug Discovery

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.3 Clinical Diagnosis

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 9. Global Proteomics Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 GENERAL ELECTRIC COMPANY

11.1.1 Company Overview

11.1.2 Equipment Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company Overview

11.2.2 Equipment Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 DANAHER

11.3.1 Company Overview

11.3.2 Equipment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Siemens Ltd.

11.4.1 Company Overview

11.4.2 Equipment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Thermo Fisher Scientific Inc.

11.5.1 Company Overview

11.5.2 Equipment Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Agilent Technologies, Inc.

11.6.1 Company Overview

11.6.2 Equipment Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Genzyme Corporation

11.7.1 Overview

11.7.2 Equipment Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Biognosys AG

11.8.1 Overview

11.8.2 Equipment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Bruker

11.9.1 Overview

11.9.2 Equipment Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Luminex Corporation

11.10.1 Overview

11.10.2 Equipment Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Merck KGaA

11.11.1 Overview

11.11.2 Equipment Overview

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 PerkinElmer Inc.

11.12.1 Overview

11.12.2 Equipment Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 WATERS

11.13.1 Overview

11.13.2 Equipment Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Caprion Biosciences Inc.

11.14.1 Overview

11.14.2 Equipment Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEOโ€™s View point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Proteomics Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Proteomics Market Synopsis, 2023-2030

Table 2 Global Proteomics Market Estimates and Forecast, 2023-2030 (USD Million)

Table 3 Global Proteomics Market, by Region, 2023-2030 (USD Million)

Table 4 Global Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 5 Global Proteomics Market, by Services, 2023-2030 (USD Million)

Table 6 Global Proteomics Market, by Application, 2023-2030 (USD Million)

Table 7 North America: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 8 North America: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 9 North America: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 10 US: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 11 US: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 12 US: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 13 Canada: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 14 Canada: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 15 Canada: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 16 South America: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 17 South America: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 18 South America: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 19 Europe: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 20 Europe: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 21 Europe: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 22 Western Europe: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 23 Western Europe: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 24 Western Europe: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 25 Eastern Europe: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 26 Eastern Europe: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 27 Eastern Europe: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 28 Asia-Pacific: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 29 Asia-Pacific: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 30 Asia-Pacific: Proteomics Market, by Application, 2023-2030 (USD Million)

Table 31 Middle East & Africa: Proteomics Market, by Equipment, 2023-2030 (USD Million)

Table 32 Middle East & Africa: Proteomics Market, by Services, 2023-2030 (USD Million)

Table 33 Middle East & Africa: Proteomics Market, by Application, 2023-2030 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Proteomics Market

Figure 3 Market Dynamics for Global Proteomics Market

Figure 4 Global Proteomics Market Share, by Equipment, 2023

Figure 5 Global Proteomics Market Share, by Services, 2023

Figure 6 Global Proteomics Market Share, by Application, 2023

Figure 7 Global Proteomics Market Share, by Region, 2023

Figure 8 North America: Proteomics Market Share, by Country, 2023

Figure 9 Europe: Proteomics Market Share, by Country, 2023

Figure 10 Asia-Pacific: Proteomics Market Share, by Country, 2023

Figure 11 Middle East & Africa: Proteomics Market Share, by Country, 2023

Figure 12 Global Proteomics Market: Company Share Analysis, 2023 (%)

Figure 13 GENERAL ELECTRIC COMPANY: Key Financials

Figure 14 GENERAL ELECTRIC COMPANY: Segmental Revenue

Figure 15 GENERAL ELECTRIC COMPANY: Geographical Revenue

Figure 16 Bio-Rad Laboratories, Inc.: Key Financials

Figure 17 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 18 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 19 DANAHER: Key Financials

Figure 20 DANAHER: Segmental Revenue

Figure 21 DANAHER: Geographical Revenue

Figure 22 Siemens Ltd.: Key Financials

Figure 23 Siemens Ltd.: Segmental Revenue

Figure 24 Siemens Ltd.: Geographical Revenue

Figure 25 Thermo Fisher Scientific Inc.: Key Financials

Figure 26 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 27 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 28 Agilent Technologies, Inc.: Key Financials

Figure 29 Agilent Technologies, Inc.: Segmental Revenue

Figure 30 Agilent Technologies, Inc.: Geographical Revenue

Figure 31 Genzyme Corporation: Key Financials

Figure 32 Genzyme Corporation: Segmental Revenue

Figure 33 Genzyme Corporation: Geographical Revenue

Figure 34 Biognosys AG: Key Financials

Figure 35 Biognosys AG: Segmental Revenue

Figure 36 Biognosys AG: Geographical Revenue

Figure 37 Bruker: Key Financials

Figure 38 Bruker: Segmental Revenue

Figure 39 Bruker: Geographical Revenue

Figure 40 Luminex Corporation: Key Financials

Figure 41 Luminex Corporation: Segmental Revenue

Figure 42 Luminex Corporation: Geographical Revenue

Figure 43 Merck KGaA: Key Financials

Figure 44 Merck KGaA: Segmental Revenue

Figure 45 Merck KGaA: Geographical Revenue

Figure 46 PerkinElmer Inc.: Key Financials

Figure 47 PerkinElmer Inc.: Segmental Revenue

Figure 48 PerkinElmer Inc.: Geographical Revenue

Figure 49 WATERS: Key Financials

Figure 50 WATERS: Segmental Revenue

Figure 51 WATERS: Geographical Revenue

Figure 52 Caprion Biosciences Inc.: Key Financials

Figure 53 Caprion Biosciences Inc.: Segmental Revenue

Figure 54 Caprion Biosciences Inc.: Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.